Genomics Industry Tries New Strategies to Engage Community Oncologists
Streamlined prescribing and reimbursement, patient education tools aim to overcome barriers to adoption of genetic testing.
Head and Neck Cancer
HEAD AND NECK CANCER ADVISOR
FEATURED CONTENT
-
-
A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials
The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated. -
Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer
Pooling data from physicians and patients appears to be an efficient way to answer urgent questions. -
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing. -
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.
HEAD AND NECK CANCER NEWS
New Dosing Schedule Approved for All Keytruda Indications
Promising Clinical Activity for RT Plus ICIs in Locally Advanced Head and Neck Cancers
Short-Term Mortality Risks Appear Higher in HPV-Negative Oropharyngeal Cancer
Endoscopic Approaches Feasible in Surgery for Sinonasal Cancer
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Want to read more?
Please login or register first to view this content.
Next post in Head and Neck Cancer
